Safety and Efficacy of Hunterase

计划入组 6 人 · 首次发布于 2012 年 7 月 20 日

An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)

计划入组 30 人 · 首次发布于 2026 年 1 月 15 日

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

计划入组 20 人 · 首次发布于 2020 年 8 月 28 日

CCZ bromelain fraction (Incitive)

Chlorotoxin

Idursulfase beta

Rx

IMV Inc.

ICN PHARMACEUTICALS

India

Ico Therapeutics Inc.

Canada

GC Biopharma's Hunterase ICV Approved in Russia for Severe Hunter Syndrome

GC Biopharma's Hunterase wins approval in India and Taiwan, expanding reach in Asia's rare disease market

GC Biopharma and Novel Pharma Initiate Phase I Trial of GC1130A for Sanfilippo Syndrome Type A